Aernoud Fiolet

Clinical implications and future perspectives Parts of this chapter have been published before. 1,2,3 1. Fiolet ATL, Nidorf SM, Cornel JH. Colchicine for secondary prevention in coronary disease. European Heart Journal 2021;42:1060-1061 2. Fiolet ATL, Opstal TSJ, Silvis MJM, Cornel JH, Mosterd, A. Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tail. Netherlands Heart Journal, in print 3. Fiolet ATL, Opstal TSJ, Thompson PL, Cornel JH. Colchicine in Acute Coronary Syndrome: When to Commence? American College of Cardiology. http://www.acc.org . Sept 15, 2021.